The Market Online Video

HAVN Life Sciences: a biotech company developing technology-focused, data-driven psychedelic therapies

HAVN Life Sciences is a biotech company focused on psychedelic therapies.

Race successfully raises $1.4M for chemotherapy drug

Race Oncology has announced a successful $1.4 million placement for the clinical projects of its cancer…

Fujifilm given chance to get its hands on cell therapy product

It's been nearly a full month since Aussie medical cell company Cynata Therapeutics was propositioned for…

Oventus supplies its O₂Vent to two U.S. companies

An additional two U.S. sleep medicine groups have agreed to take on Oventus' O₂Vent sleep technology…

Dotz partners with Slalom for development of BioDotz

Dotz Nano has partnered with Slalom Capital for the development of BioDotz™ technology on hemp plants

Bod and UTS study keeps skin young and shares up

Bod Australia has gained 20 per cent after announcing a new solution to help stop the…

Nuheara registered as provider to NDIS to support Autism

Nuheara has announced that it has been approved as a registered provider to Australia's National Disability…

Kazia Therapeutics go-ahead with clinical study of ovarian cancer

Australian oncology company Kazia Therapeutics has completed the recruitment of patients for Part B of its…

Impression Healthcare begins its second Phase of sleep apnoea clinical trial

Impression Healthcare has successfully registered its second clinical trial to investigate the efficacy of its IHL-42X…

HeraMED partners with leading European electronics distributor for HeraBEAT

Medical technology company HeraMED has secured a €30,000 initial order with a major electronics distributor, Duttenhofer…